tetano
Editor, Senior Moderator
PLoS One
. 2022 Sep 2;17(9):e0274222.
doi: 10.1371/journal.pone.0274222. eCollection 2022.
Clinical impact of the rapid molecular detection of RSV and influenza A and B viruses in the emergency department
Nicolas Yin[SUP] 1 [/SUP], Marc Van Nuffelen[SUP] 2 [/SUP], Magali Bartiaux[SUP] 3 [/SUP], Thierry Préseau[SUP] 4 [/SUP], Inge Roggen[SUP] 5 [/SUP], Sabrina Delaunoy[SUP] 1 [/SUP], Bhavna Mahadeb[SUP] 1 [/SUP], Hafid Dahma[SUP] 1 [/SUP], Laurent Busson[SUP] 1 [/SUP], Olivier Vandenberg[SUP] 6 7 8 [/SUP], Marie Hallin[SUP] 1 7 [/SUP]
Affiliations
Abstract
Introduction: Using respiratory virus rapid diagnostic tests in the emergency department could allow better and faster clinical management. Point-of-care PCR instruments now provide results in less than 30 minutes. The objective of this study was to assess the impact of the use of a rapid molecular diagnostic test, the cobas® Influenza A/B & RSV Assay, during the clinical management of emergency department patients.
Methods: Patients (adults and children) requiring admission or suffering from an underlying condition at risk of respiratory complications were prospectively recruited in the emergency department of four hospitals in the Brussels region. Physicians' intentions regarding admission, isolation, antibiotic, and antiviral use were collected before and after performing the rapid molecular test. Additionally, a comparison of the analytical performance of this test against antigen rapid tests and viral culture was performed as well as a time-to-result evaluation.
Results: Among the 293 patients recruited, 90 had a positive PCR, whereas 44 had a positive antigen test. PCR yielded a sensitivity of 100% for all targets. Antigen tests yielded sensitivities ranging from 66.7% for influenza B to 83.3% for respiratory syncytial virus (RSV). The use of PCR allowed a decrease in the overall need for isolation and treatment by limiting the isolation of negative patients and antibiotic use for positive patients. Meanwhile, antiviral treatments better targeted patients with a positive influenza PCR.
Conclusion: The use of a rapid influenza and RSV molecular test improves the clinical management of patients admitted to the emergency department by providing a fast and reliable result. Their additional cost compared to antigen tests should be balanced with the benefit of their analytical performance, leading to efficient reductions in the need for isolation and antibiotic use.
. 2022 Sep 2;17(9):e0274222.
doi: 10.1371/journal.pone.0274222. eCollection 2022.
Clinical impact of the rapid molecular detection of RSV and influenza A and B viruses in the emergency department
Nicolas Yin[SUP] 1 [/SUP], Marc Van Nuffelen[SUP] 2 [/SUP], Magali Bartiaux[SUP] 3 [/SUP], Thierry Préseau[SUP] 4 [/SUP], Inge Roggen[SUP] 5 [/SUP], Sabrina Delaunoy[SUP] 1 [/SUP], Bhavna Mahadeb[SUP] 1 [/SUP], Hafid Dahma[SUP] 1 [/SUP], Laurent Busson[SUP] 1 [/SUP], Olivier Vandenberg[SUP] 6 7 8 [/SUP], Marie Hallin[SUP] 1 7 [/SUP]
Affiliations
- PMID: 36054246
- DOI: 10.1371/journal.pone.0274222
Abstract
Introduction: Using respiratory virus rapid diagnostic tests in the emergency department could allow better and faster clinical management. Point-of-care PCR instruments now provide results in less than 30 minutes. The objective of this study was to assess the impact of the use of a rapid molecular diagnostic test, the cobas® Influenza A/B & RSV Assay, during the clinical management of emergency department patients.
Methods: Patients (adults and children) requiring admission or suffering from an underlying condition at risk of respiratory complications were prospectively recruited in the emergency department of four hospitals in the Brussels region. Physicians' intentions regarding admission, isolation, antibiotic, and antiviral use were collected before and after performing the rapid molecular test. Additionally, a comparison of the analytical performance of this test against antigen rapid tests and viral culture was performed as well as a time-to-result evaluation.
Results: Among the 293 patients recruited, 90 had a positive PCR, whereas 44 had a positive antigen test. PCR yielded a sensitivity of 100% for all targets. Antigen tests yielded sensitivities ranging from 66.7% for influenza B to 83.3% for respiratory syncytial virus (RSV). The use of PCR allowed a decrease in the overall need for isolation and treatment by limiting the isolation of negative patients and antibiotic use for positive patients. Meanwhile, antiviral treatments better targeted patients with a positive influenza PCR.
Conclusion: The use of a rapid influenza and RSV molecular test improves the clinical management of patients admitted to the emergency department by providing a fast and reliable result. Their additional cost compared to antigen tests should be balanced with the benefit of their analytical performance, leading to efficient reductions in the need for isolation and antibiotic use.